Additionally, miR-193-5p acts as a tumour suppressor in CRC [202] and enhances the inhibition of CXCR4 when combined with 5-fluorouracil (5-FU) and oxaliplatin, reducing chemoresistance [203]. Here, CXCR4 is linked to colorectal carcinoma.